Wound Care
SUTUREGARD Medical
HQ Location:
Portland, OR
CEO
Dr. Dan Ladizinsky
EST.
2015
Lead Product:
HEMIGARD® — adhesive suture retention device for high-tension wound closure and dehiscence prevention.
SUTUREGARD develops wound closure technologies that help surgeons close high-tension or fragile-skin wounds while reducing tearing and dehiscence risk. Its HEMIGARD® device acts as a load-transferring skin anchor for complex surgical closures.